Chicago hospital resists pressure to provide ivermectin treatment for COVID-19

In this file photo, a healthcare professional shows a bottle of Ivermectin, a drug approved by the National Institute for Food and Drug Surveillance (INVIMA) for the treatment of patients with mild, asymptomatic or suspicious COVID-19, as part of a study by the Center for Pediatric Studies infectious diseases in Cali, Colombia, July 21, 2020. (LUIS ROBAYO / AFP via Getty Images)

Give a Comment